Agneta Edberg

Agneta Edberg has over 25 years’ experience from leading positions in the life sciences industry. She has been CEO at Mylan AB and the Swedish Pharmaceutical Insurance and has held leading positions within Pfizer, Bactiguard and Cilag (Johnson & Johnson). Agneta Edberg has been chairman of the board of Immunicum AB, an immuno-oncology company listed on the Stockholm Stock Exchange. She is also chairman of the board of Idogen AB and participates on the board of the Vinnova project CAMP, Centre for Advanced Medical Products. Since 2020, she participates on the board of the Vinnova Competence Center NextGenNK, focusing on the development of next-generation NK cell-based immunotherapies.